Price $4.95 |
Market Cap
166.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.05
|
P/S
12.03
|
Dividend %
-
|
|
P/CF
10.9
|
P/FCF
-
|
Op. Cash Flow
-17K
|
FCF
-0.7
|
|
Op. Margin
-196.40%
|
Net Margin
-170.60%
|
ROE
-74.20%
|
ROI
-63.10%
|
|
ROA
-51.10%
|
EPS Growth
34.20%
|
Current Ratio
0.8
|
Debt/Equity
12.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aviragen Therapeutics Inc (AVIR) | $0.73 | - | - | 25.1M | Strong Buy |
| IRIDEX Corporation (IRIX) | $9.49 | - | - | 107.6M | Strong Buy |
| American Renal Associates Hold (ARA) | $12.70 | - | - | 466.5M | Strong Buy |
| DURECT Corporation (DRRX) | $1.81 | - | - | 258.7M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $16.60 | - | - | 626.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
